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We have found that chain A of alpha-2-HS-glycoprotein contains two cystatin domains that show closest similarity to 
those of kininogen. Most likely, the two proteins diverged after the primary duplication of a single cystatin domain as 
the two cystatin domains of alpha-2-HS-glycoprotein are more similar, especially in disulfide bonding, to the correspond- 
ing domains of kininogen than to each other. We also propose that the carboxyl-terminal (non-cystatin) parts of kinino- 
gen and alpha-2-HS-glycoprotein contain homologous segments. We suggest that alpha-2-HS-glycoprotein may act as 
an inhibitor of the cysteine proteinases responsible for bone resorption. We have also found that fetuin is closely related 
to alpha-2-HS-glycoprotein. 
Cysteine proteinase inhibitor; %-HS-glycoprotein; Kininogen; Plasma protein; Bone resorption; Fetuin 
1. INTRODUCTION 
The cystatin superfamily includes inhibitors of 
cysteine proteinases found in various tissues and 
body fluids of mammals and birds [l-3]. These in- 
hibitors are likely to be found also in other 
vertebrates, as they are probably present in a chon- 
drichthyan fish [4]. Cystatins, which are ex- 
tracellular, have about 115 amino acids and two 
disulfide bonds. Homologous intracellular in- 
hibitors with 100 amino acids and no disulfide 
bonds are known as stefins. Ohkubo et al. [5] 
established that the carboxyl two-thirds of the 
heavy chain of kininogen contains two domains 
similar and clearly homologous to cystatins and 
stefins. Salvesen et al. [6] demonstrated that the re- 
maining amino-terminal domain of kininogens is 
also homologous, although less similar, to 
cystatins. Each of the three domains is encoded by 
three contiguous exons and both the gene structure 
and the protein sequence suggest that the 
kininogen gene originated by two successive 
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duplications [7,8]. Duplicated more recently was 
the carboxyl-terminal cystatin domain of the two- 
domain intermediate form, because the second and 
third domains of the present kininogen are more 
similar to each other than either is to the amino- 
terminal domain. The first domain does not show 
any inhibitory activity whereas the other two do- 
mains inhibit papain and cathepsin L, but only the 
second (middle) domain inhibits calpain [6]. 
We discovered that at least two cystatin domains 
are present in chain A of alpha-2-HS-glycoprotein 
(alpha-ZHS). The alpha-2-HS molecule is com- 
posed of two chains; the sequence of the longer 
chain A was determined by Yoshioka [9] and that 
of chain B by Gejyo et al. [lo]. Recently, Lee et al. 
[l l] determined the sequence of the single mRNA 
transcript coding for the precursor, including the 
signal sequence, both chains, and the connecting 
peptide. Alpha-2-HS occurs in plasma and, at 
levels much higher than other plasma proteins, in 
the matrix of bone and dentine; this association 
with mineralized tissues and the affinity for 
calcium and barium ions suggest some role in 
mineral balance. Alpha-2-HS is known also as an 
acute phase negative reactant. The function of 
alpha-ZHS remains unknown. 
We also found that the known sequence frag- 
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Fig.1. Alignment of cystatins from chicken [19,20], cattle [21], and man [17,22,23] with the cystatin domains of kininogens from cattle 
[24], man [5], and rat [25] and the cystatin domains of alpha-2-HS-glycoprotein [9,11]. Triangles mark the intron-exon junctions in 
the human kininogen [7] and their orientation denotes type of junction: ) l/2, 4 2/3, v 3/l; the numbers refer to the positions 
of adjacent nucleotides within their codons (in the first two cases the triangles point to the residue coded by the spliced codon). Boxed 
with solid lines are positions probably essential for inhibitory activity [l]. Boxed with a broken line are signal sequences. 
ment of fetuin [12] is very similar and evidently 
homologous to the first cystatin domain of 
alpha-2-HS. Fetuin is a major plasma protein of 
fetal ruminants and probably other artiodactyls. 
2. RESULTS AND DISCUSSION 
A routine search of our Protein Sequence 
Database using the FASTP program of Lipman 
and Pearson [13] revealed that alpha-2-HS is 
similar to the bovine kininogens I and II (with op- 
timized scores of 139 and 140). Comparison of the 
sequences using our ALIGN program [14] showed 
that the statistically significant similarity is 
restricted to the cystatin domains contained in the 
heavy chain of kininogens. Alpha-2-HS is most 
similar to bovine kininogen II, with an ALIGN 
score of 5.9 SD between the corresponding amino- 
terminal domains and scores of 8.7 and 7.2 SD be- 
tween the alpha-2-HS second domain and the 
kininogen second and third domains. 
The homology of fetuin and alpha-2-HS is evi- 
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Fig.2. Average ALIGN scores between the cystatin domains in 
alpha-2-HS-glycoprotein and kininogens. 
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Fig.3. Comparison of the domain structure and disulfide 
bonding in alpha-2-HS and HMW kininogen. I-III, cystatin 
domains; CT, non-cystatin, carboxyl-terminal domains; B, 
bradykinin domain. Arrows mark the intron-exon junctions in 
kininogen. Except for the carboxyl-terminal domain of 
kininogen, the domains are drawn to scale. 
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Fig.4. Phylogeny of the cystatin domains generated by the 
MATTOP tree program described in Hunt et al. 1261. 
dent (fig.1). The amino-terminal fragment of 
fetuin is clearly more similar to the first than to the 
second cystatin domain of alpha-2-HS: 52% of the 
residues are identical and 9 of these are unique to 
these two sequences. 
The homology of the two amino-terminal do- 
mains of alpha-2-HS to the three cystatin domains 
of kininogens is demonstrated by the alignment 
(fig.1) and the ALIGN scores (fig.2). Both cystatin 
domains of alpha-2-HS are more similar to those 
of kininogens than to cystatins, the similarity to 
stefins being even more remote. The corresponding 
domains in alpha-2-HS and kininogen are more 
similar to each other than are the first and the 
second domains within each protein (fig.2). The 
first alpha-2-HS domain scores best with the first 
kininogen domain, and the second alpha-2-HS do- 
main scores better with either the second or third 
than with the first kininogen domain. Common to 
the amino-terminal parts of the second domain of 
alpha-2-HS and the second and third domain of 
kininogen are two cysteines, indicative of a small 
disulfide loop (fig.3), which is unique to these do- 
mains (absent in the first domains and cystatins). 
This parallel pattern of similarity between domains 
suggests that the genes coding for alpha-2-HS and 
a protokininogen diverged by duplication of their 
ancestral gene after the intragenic duplication of 
the single cystatin domain and before the duplica- 
tion of the second cystatin domain, as indicated in 
the computer-derived phylogenetic tree (fig.4). 
All cysteines are conserved between the cor- 
responding cystatin domains in the mature 
kininogen and alpha-2-HS (fig.3). In kininogen 
[8,15,16] all but the amino-terminal cysteine 
(alignment position 20) of the mature protein form 
intradomain disulfide loops and the amino- 
terminal cysteine bonds with the carboxyl-terminal 
cysteine in the light chain (Cys-596 in the human 
mature HMW kininogen). In alpha-2-HS, the two 
chains are known to be connected by a disulfide 
bond [l l] and, if the intradomain bonds are as in 
kininogen, the amino-terminal cysteine is the only 
one remaining to form this bond with the carboxyl- 
terminal cysteine in chain B. It is therefore very 
likely that the interchain bonds in alpha-2-HS and 
kininogen are also homologous (conserved from 
the common ancestral molecule). The sequences 
surrounding the carboxyl-terminal cysteines are 
very similar in alpha-ZHS (PPCPGR) and in the 
human (PKCPGR) and bovine (PKCPSR) HMW 
kininogens, but the remaining parts of the 
carboxyl-terminal, non-cystatin domains show lit- 
tle similarity and that of HMW kininogen is much 
longer than that of alpha-2-HS. However, the 
combined evidence from their corresponding 
carboxyl-terminal positions relative to the 
homologous cystatin domains, and from the ap- 
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parent conservation of the interchain disulfide 
bond, suggests that both proteins inherited a car- 
boxy& non-cystatin part from their common 
ancestor. Subsequent evolutionary changes, 
possibly including incorporation of unrelated 
segments into one or both molecules, produced 
dissimilar sequences except surrounding the 
carboxyl-terminal cysteines. 
By circumstantial evidence, the reactive site of 
cystatin-related inhibitors is expected to involve a 
string of five residues (QXVXG, predominantly 
QVVAG) at alignment positions 59-63 (fig.1) [l]. 
Positions 59-63 are occupied in alpha-2-HS by the 
sequence QQPSG, which has two residues 
unknown in other cystatin domains with inhibitory 
properties. However, the human salivary cystatins, 
which are strong inhibitors [17], also differ from 
all others by one (QTVGG in cystatin SN) or two 
(QTFGG in cystatin S) residues at this site, the 
replacement of valine by threonine being clearly 
non-conservative. Also highly conserved through- 
out the inhibitory domains is glycine at alignment 
position 13, which in the human cystatin S, 
cystatin SN, and stefin is preceded by proline. The 
first domain of alpha-ZHS has a glycine at align- 
ment position 12, which is also preceded by 
proline. 
Delaisse et al. [18] demonstrated that at least 
three cysteine proteinases, cathepsin B and two 
probably novel enzymes, participate in the resorp- 
tion of bone in rodents. In view of the unexplained 
association of alpha-ZHS with bone tissues, there 
is a good possibility that its amino-terminal do- 
main acts as a specialized inhibitor of the pro- 
teinases responsible for the resorption of bone. 
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